Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat

od Fitzsimons, Helen L., Riban, Veronique, Bland, Ross J., Wendelken, Jennifer L., Sapan, Christine V., During, Matthew J.
Wydane 2010

Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

od Mascola, John R., Lewis, Mark G., Stiegler, Gabriela, Harris, Dawn, VanCott, Thomas C., Hayes, Deborah, Louder, Mark K., Brown, Charles R., Sapan, Christine V., Frankel, Sarah S., Lu, Yichen, Robb, Merlin L., Katinger, Hermann, Birx, Deborah L.
Wydane 1999

Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease

od Niethammer, Martin, Tang, Chris C., LeWitt, Peter A., Rezai, Ali R., Leehey, Maureen A., Ojemann, Steven G., Flaherty, Alice W., Eskandar, Emad N., Kostyk, Sandra K., Sarkar, Atom, Siddiqui, Mustafa S., Tatter, Stephen B., Schwalb, Jason M., Poston, Kathleen L., Henderson, Jaimie M., Kurlan, Roger M., Richard, Irene H., Sapan, Christine V., Eidelberg, David, During, Matthew J., Kaplitt, Michael G., Feigin, Andrew
Wydane w JCI Insight (2017)